Pfizer’s German partner, BioNTech, achieves breakthrough in quest for multiple sclerosis vaccine

BioNTech, the German biotechnology company that developed a coronavirus vaccine with U.S. drugmaker Pfizer, has found some success using the same mRNA technique while attempting to treat multiple sclerosis in lab mice.

read more »